A practical reference on Dual agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-20 and is reviewed periodically as new material appears.
Cold-chain handling is standard for formulated product, with dry powder stored frozen and ready-to-use solutions refrigerated. Light exposure is minimized because photodegradation of certain amino acid side chains is possible. Shipping and temperature-excursion studies are used to establish whether short deviations affect quality attributes. Documentation supplied with research material usually includes a certificate of analysis listing purity, identity confirmation, and water or residual solvent content. Users are expected to confirm that material meets the stated specification before use.
Identity and purity of tirzepatide are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Because the molecule carries several modifications, gradient conditions are adjusted to resolve the intact peptide from deamidation and oxidation products. Enzymatic digestion followed by peptide mapping confirms the primary sequence and locates specific modifications. Quantitation in biological matrices typically uses liquid chromatography with tandem mass spectrometry after solid-phase extraction. Immunoassays are used less often, since antibody cross-reactivity with closely related peptides can bias results.
The peptide shares degradation routes common to modified peptides: deamidation of asparagine and glutamine residues, oxidation of methionine, and backbone hydrolysis under extreme pH. Lyophilized material is generally more stable than a solution, and residual water content directly affects the rate of hydrolysis. In liquid form, aggregation and visible particles can appear after agitation or repeated freeze-thaw cycles. Stability studies therefore track monomer content, aggregate content, and potency over months under defined temperature and humidity.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
| Property | Value | Notes |
|---|---|---|
| Typical analytical method | Reversed-phase HPLC with UV detection | Often paired with mass spectrometry for identity |
| Common synonyms | GIP/GLP-1 dual agonist; LY3298176 | Development codes appear in earlier literature |
| Purity specification | Usually 95% or higher by HPLC area | Research-grade lots are often 98% or higher |
| Solution storage | 2–8 °C, protected from light | Short term; avoid repeated freeze-thaw cycles |
| Dry powder storage | −20 °C or below, desiccated | Protected from moisture and light |
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
To achieve this goal, they demonstrated that solution-processed perovskites can spontaneously form submicrometre-scale crystal platelets, which can efficiently extract light from the device. These perovskites are formed via the introduction of amino acid additives into the perovskite precursor solutions. In addition, their method is able to passivate perovskite surface defects and reduce nonradiative recombination. Therefore, by improving the light outcoupling and reducing nonradiative losses, Cao and his colleagues successfully achieved PLED with EQE up to 20.7%. Lin and his colleague used a different approach to generate high EQE. Instead of modifying the microstructure of perovskite layer, they chose to adopt a new strategy for managing the compositional distribution in the device—an approach that simultaneously provides high luminescence and balanced charge injection. In other words, they still used flat emissive layer, but tried to optimize the balance of electrons and holes injected into the perovskite, so as to make the most efficient use of the charge carriers. Moreover, in the perovskite layer, the crystals are perfectly enclosed by MABr additive (where MA is CH3NH3). The MABr shell passivates the nonradiative defects that would otherwise be present perovskite crystals, resulting in reduction of the nonradiative recombination. Therefore, by balancing charge injection and decreasing nonradiative losses, Lin and his colleagues developed PLED with EQE up to 20.3%.
The GTP-binding domain is conserved in both EF-1alpha/EF-Tu and also in EF-2/EF-G and thus seems typical for GTP-dependent proteins which bind non-initiator tRNAs to the ribosome. The GTP-binding translation factor family also includes the eukaryotic peptide chain release factor GTP-binding subunits and prokaryotic peptide chain release factor 3 (RF-3); the prokaryotic GTP-binding protein lepA and its homologue in yeast (GUF1) and Caenorhabditis elegans (ZK1236.1); yeast HBS1; rat Eef1a1 (formerly "statin S1"); and the prokaryotic selenocysteine-specific elongation factor selB.
=== Research === In AI safety, local solutions focus on individual AI systems, ensuring they are safe and beneficial, while global solutions seek to implement safety measures for all AI systems across various jurisdictions. AI safety governance research ranges from foundational investigations into the potential impacts of AI to specific applications. On the foundational side, researchers have argued that AI could transform many aspects of society due to its broad applicability, comparing it to electricity and the steam engine. Some work has focused on anticipating specific risks that may arise from these impacts – for example, risks from mass unemployment, weaponization, disinformation, surveillance, and the concentration of power. Other work explores underlying risk factors such as the difficulty of monitoring the rapidly evolving AI industry, the availability of AI models, and 'race to the bottom' dynamics. Allan Dafoe, the head of longterm governance and strategy at DeepMind has emphasized the dangers of racing and the potential need for cooperation: "it may be close to a necessary and sufficient condition for AI safety and alignment that there be a high degree of caution prior to deploying advanced powerful systems; however, if actors are competing in a domain with large returns to first-movers or relative advantage, then they will be pressured to choose a sub-optimal level of caution". A research stream focuses on developing approaches, frameworks, and methods to assess AI accountability, guiding and promoting audits of AI-based systems.
== Biochemical methods == Co-immunoprecipitation is considered to be the gold standard assay for protein–protein interactions, especially when it is performed with endogenous (not overexpressed and not tagged) proteins. The protein of interest is isolated with a specific antibody. Interaction partners which stick to this protein are subsequently identified by Western blotting. Interactions detected by this approach are considered to be real. However, this method can only verify interactions between suspected interaction partners. Thus, it is not a screening approach. A note of caution also is that immunoprecipitation experiments reveal direct and indirect interactions. Thus, positive results may indicate that two proteins interact directly or may interact via one or more bridging molecules. This could include bridging proteins, nucleic acids (DNA or RNA), or other molecules. Bimolecular fluorescence complementation (BiFC) is a new technique in observing the interactions of proteins. Combining with other new techniques, this method can be used to screen protein–protein interactions and their modulators, DERB. Affinity electrophoresis as used for estimation of binding constants, as for instance in lectin affinity electrophoresis or characterization of molecules with specific features like glycan content or ligand binding. Pull-down assays are a common variation of immunoprecipitation and immunoelectrophoresis and are used identically, although this approach is more amenable to an initial screen for interacting proteins.
== Plot == Maia Marten is a prosecutor and mother to her diabetic son Noah, living in London. On the day she is scheduled to appear in court for the trial of crime boss Tommy Boyd, she drops Noah off at school, then goes for a run. While on her run, she receives a call coming from Noah's phone from an unnamed man in Boyd's employ. The Caller informs Maia that he has kidnapped Noah and orders her to follow his instructions to ensure Noah’s safe release. He also reveals that he has hacked her phone and is tracking her, leaving her unable to call others for help. The Caller guides Maia to a dumpster, where she finds Noah's backpack containing a gun that was used by Boyd. The Caller tells Maia he has placed Noah in a diabetic coma using his insulin pump. He instructs her to run to the Excelsus Hotel, where key witness Radian Tafa is being kept under police guard, and use the gun to kill him, telling her that if she does not succeed within one hour, Noah will die. Maia begins to run, still on the phone with the Caller, who taunts her with private information he has learned from hacking her, as well as her colleague and romantic interest Ted. She attempts to steal a phone from passersby to send a text to Ted but is unable to do so. As the Caller interrogates Maia about her father's murder, allegedly committed by her abused mother, she is struck by a car and awakens several minutes later in an ambulance. Leaping out, Maia enters the London Underground to make up time, against the Caller's orders.
Sources: en.wikipedia.org
On May 23, 1871, at the instigation of anarchist Jean-Louis Pindy, Communards set fire to many public buildings, including Paris’ City Hall. The civil records, stored in an annex at 4 Avenue Victoria, were the first to burn. Within hours, the originals of civil and parish registers were destroyed, along with the collection of the Historical Library of Paris, which had been transferred to City Hall. Just days earlier, on May 17, 1871, Louise Michel had declared at the "Club de la Trinité": "Paris will be ours or will no longer exist!" On May 24, 1871, the day after City Hall’s destruction, Communards burned the Palais de Justice on orders from Blanquist Théophile Ferré. The second copies of civil and parish registers for Paris and all communes in the Seine were lost as well. Besides civil registry offices, much of the Palais was destroyed: the offices of the Court of First Instance; the General Prosecutor’s Office; the Public Prosecutor’s Office; judges’ chambers; two criminal courts (completed just two years earlier); much of the Court of Cassation; the Court of Appeal; the Great Hall and Grand Chamber; the Correctional Police; and the archives.
Structural and computational studies have revealed that the metal binds the two carbonyl oxygens of the methylglyoxal moiety at two of its coordination sites, stabilizing the enediolate anion intermediate. Another unusual property of glyoxalase I is its inconsistent stereospecificity. The first step of its reaction mechanism (the abstraction of the proton from C1 and subsequent protonation of O2) is not stereospecific and works equally well regardless of the initial chirality at C1 in the hemithioacetal substrate. The resulting enediolate intermediate is achiral, but the second step of the reaction mechanism (the abstraction of a proton from O1 and subsequent protonation of C2) is definitely stereospecific, producing only the (S) form of D-lactoylglutathione. This is believed to result from the two glutamates bound oppositely on the metal ion; either one is able to carry out the first step, but only one is able to carry out the second step. The reason from this asymmetry is not yet fully determined.
Bicalutamide has an antiandrogenic efficacy that is comparable to or greater than that of flutamide, and would be expected to produce similar therapeutic benefits. Other androgen-dependent skin and hair conditions, such as seborrhea and pattern hair loss, may also be treated by bicalutamide. In addition to acne, flutamide has been found to produce an 80% or greater decrease in scores of seborrhea and androgen-dependent scalp hair loss. Moreover, in combination with a combined birth control pill, flutamide treatment resulted in an increase in cosmetically acceptable scalp hair density in almost all women suffering from pattern hair loss in one small study. Bicalutamide is an appealing alternative to flutamide for the treatment of androgen-dependent skin and hair conditions in women because flutamide has a considerable risk of serious liver toxicity, which bicalutamide does not share. Antiandrogens like flutamide and bicalutamide are male-specific teratogens which can feminize male fetuses due to their antiandrogen effects. For this reason, they are not recommended by the U.S.Tooltip United States Food and Drug Administration for use in women. Because of this risk, it is strongly recommended that antiandrogens only be used to treat women who are of reproductive age in conjunction with adequate contraception. Birth control pills, which contain an estrogen and a progestin, are typically used for this purpose.
=== Removal of additives === In 2011, food blogger and activist Vani Hari noted that Chick-fil-A sandwiches contained nearly 100 ingredients, including peanut oil preserved with tert-butylhydroquinone (TBHQ), made from butane. In October 2012, Chick-fil-A invited Hari to meet with company executives at its headquarters. In December 2013, Chick-fil-A said that it was removing high-fructose corn syrup and artificial dyes, and was testing a new peanut oil. Like other companies, Chick-fil-A does not publicly announce such changes unless already in the news, because it focuses on these ingredients.
Open to people of good moral character of Polish, Lithuanian, or Slavic descent and of the Roman Catholic, Byzantine Catholic or Greek Catholic Church or those married to one of the acceptable ethics and a member of the approved churches. Honorary membership is given to those who rendered a great service to the Association, Catholicism, the United States, or mankind in general. The minimum age is 15, though juvenile insurance/membership was available. In 1967 it had 24,500 members in 1979 16,000 in 105 groups. No ritual, but there is an oath. Offers scholarships, organizes folk dances, polka and Halloween parties, etc. Involved with the Catholic church. Patron saint is St. John Cantius, holds Masses and organized a pilgrimage to the National Shrine of Our Lady of Czestochowa in Doylestown, Pennsylvania. Polish Falcons of America Polish National Alliance of Brooklyn - Founded in 1903. Despite the name, it had members and was licensed to sell insurance in Connecticut, Michigan, Minnesota, New Jersey, and New York. Absorbed Polish American Workmen Aid Fund in 1960. Had 21,413 in 1965, approximately 12,000 in 1979 and 11,135 in 1995. Had 155 lodges in 1972, 87 in 1978. Offers Masses to its members, yearly grants to the Catholic Foundation and theological seminaries. Polish National Alliance Polish National Union (Sponjnia - Founded in February 1908 in the parish hall of St. Stanislaus Cathedral, in Scranton, Pennsylvania. Received charter by the end of the year. Women's lodges were authorized in 1909. Had difficulty retaining membership because it was actuarially unsound.
Sources: en.wikipedia.org
Reversed-phase liquid chromatography with ultraviolet detection is the usual approach, frequently combined with mass spectrometry for identity. Purity is reported as the area percentage of the main peak. Related impurities eluting near the main peak are usually summed and reported separately.
Removing water slows hydrolysis and limits aggregation, so dry powder retains its quality attributes longer than a solution. Suppliers define a shelf life and retest date for the dried form at specified temperatures. Once dissolved, the practical working lifetime shortens considerably.
It generally lists appearance, identity by mass, purity by chromatography, water or residual solvent content, and the methods used. Storage recommendations and a retest date are commonly included. Values are reported against a supplier specification rather than a single universal standard.
It is a synthetic peptide and a dual agonist of two incretin receptors. It is not a small molecule, and it is not structurally related to the older single-receptor peptide agonists.